Kidneys Home > Simulect Warnings and Precautions

You may have an increased risk for infections during treatment with Simulect. People using this anti-rejection medication may also experience serious allergic reactions to the drug. Other safety precautions with Simulect involve understanding the warnings of potential drug interactions and an increased risk for diabetes. Also, women who are pregnant or breastfeeding should talk to their healthcare provider before beginning treatment with this medicine.

What Should I Tell My Healthcare Provider?

Talk with your healthcare provider prior to receiving Simulect® (basiliximab) if you have:
  • Plans to receive a vaccination
  • A history of transplant rejection in the past
  • An infection of any kind, including a viral, fungal, or bacterial infection
  • A weakened immune system due to human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS), cancer, or any other cause
  • Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.